ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 641461 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 641461; 2) Community: the network communities that were significantly associated with the response to NSC 641461; 3) Molecule: the relationships between components within communities and NSC 641461; 4) MDR: the compounds that were significantly associated with the NSC 641461.

NSC Compound Enrichment Correlation
NSC 644945 Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6-one, 5,5a,6,8,8a,9-hexahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)- 9-[2-(dimethylamino)ethoxy]-, stereoisomer, hydrochloride 0.0100967765290133 0.66177646
NSC 665925 Null 0.0100967765290133 -0.0058915283
NSC 691240 Null 0.0100967765290133 0.40800551
NSC 707904 Null 0.0100967765290133 0.16541344
NSC 746540 Null 0.0100967765290133 -0.11380159
NSC 756404 GW843682X 0.0100967765290133 0.11682243
NSC 100880 Camptothecin 0.0135588245836371 0.58999146
NSC 144126 Null 0.0135588245836371 -0.083562945
NSC 328410 Camptothecin Derivative 0.0135588245836371 0.70183896
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0135588245836371 0.083793661
Total:68  Current:14    [First] [Prev] [Next] [Last]